Multiplan Corp
NYSE:MPLN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.21
68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Multiplan Corp
Multiplan Corp
Cost of Revenue
Multiplan Corp
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Multiplan Corp
NYSE:MPLN
|
Cost of Revenue
-$235.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cost of Revenue
-$685.9m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-21%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cost of Revenue
-$115.1m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Cost of Revenue
-$50.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Cost of Revenue
-$623.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-12%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Cost of Revenue
-$249.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Multiplan Corp
Glance View
MultiPlan Corp. provides healthcare cost management solutions. The company is headquartered in New York City, New York and currently employs 2,400 full-time employees. The company went IPO on 2020-02-10. The firm's services include analytics-based services, which uses information technology platform to offer customers analytics-based services to detect claims over-charges and recommend or negotiate fair reimbursement. Its Network-Based Services includes multiplan's primary and complementary networks in which payors can utilize its national network of contracted providers to process claims at a discount. Its payment integrity services use data, technology, and clinical expertise to identify improper, unnecessary and excessive charges before or after claims are paid. Its revenue integrity services use data, technology, and clinical expertise to improve accuracy of premiums paid to medicare advantage plans by Centers for Medicare and Medicaid Services (CMS).
See Also
What is Multiplan Corp's Cost of Revenue?
Cost of Revenue
-235.5m
USD
Based on the financial report for Dec 31, 2023, Multiplan Corp's Cost of Revenue amounts to -235.5m USD.
What is Multiplan Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
10%
Over the last year, the Cost of Revenue growth was -15%. The average annual Cost of Revenue growth rates for Multiplan Corp have been 10% over the past three years .
You don't have any saved screeners yet
